This site provides INTERCEPT product information for International audiences Select your region
One Disposable Set = Two Therapeutic Doses
With the introduction of the INTERCEPT™ dual storage processing set and development of the double dose buffy coat approach, Cerus is leading the way in ensuring that pathogen inactivation technology is economically feasible for blood centres.
The INTERCEPT dual storage container set allows blood centres to treat and split double dose platelet units (up to 8x1011 platelets per unit). The INTERCEPT dual storage set is compatible with both apheresis and buffy coat collections.
A Novel Approach: Double Dose Buffy Coat Platelets
The double dose buffy coat platelet production process can contribute significantly to the affordability of the INTERCEPT™ Blood System for platelets, translating into direct, as well as indirect financial and economic advantages.
In addition, Cerus offers a total approach to support blood centres in the implementation of the INTERCEPT™ Blood System for platelets in a cost-effective way, through double dose buffy coat platelet production. This total approach relies on the Cerus Deployment team, which has developed a sound methodology, based on extensive experience with successful implementations in blood centres of all sizes. The specially designed I-Platelet Pooling Set is just one of the assets they can deploy to add to the affordability of pathogen inactivation.
Learn more about the preservation of the in vitro function of double dose buffy coat platelets.
Have a look at the advantages of the specially designed I-Platelet Pooling Set.